0JBU Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Intellia Therapeutics Inc

Watchlist Manager

Watchlist

Price: 14.02 USD 3.09%

Market Cap: $1.6B

	Intellia Therapeutics Inc LSE:0JBU	US
	ACS Actividades de Construccion y Servicios SA F:OCI	ES
A	Arch Resources Inc SWB:ACCA	US
	Great Elm Capital Corp NASDAQ:GECC	US
H	Hitachi Ltd DUS:HIA1	JP
H	Harvey Norman Holdings Ltd XMUN:HNN	AU
S	Stabilis Solutions Inc F:QAT2	US
L	Lam Research Corp LSE:0JT5	US
G	GoGold Resources Inc XMUN:GGD	CA
	Gismondi 1754 SpA MIL:GIS	IT
E	Exxon Mobil Corp XMUN:XONA	US
D	Daimler AG XHAM:DAI	DE
	Rolls-Royce Holdings PLC F:RRU1	UK

Profitability Summary

Intellia Therapeutics Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Low Gross Margin

Negative Operating Margin

-652%

Negative 3Y Average Operating Margin

-980%

Operating Margin is Increasing

-796% > -652%

Negative Net Margin

-610%

Negative 3Y Average Net Margin

-936%

Net Margin is Increasing

-805% > -610%

Negative Free Cash Flow Margin

-585%

Negative 3Y Average Free Cash Flow Margin

-688%

Free Cash Flow Margin is Increasing

-708% > -585%

Negative ROE

-53%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-141%

ROIC is Increasing

-105% > -93%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.